Pattern of transcatheter interventional procedure have done in Cath lab and their immediate outcome: one year experience at Bangladesh Shishu hospital and institute

M. Abu Sayed Munsi; Maher Akther; M. Khalid Ebna Shahid Khan; Chandan Saha

doi:10.18203/2349-3291.ijcp20233954

Authors

M. Abu Sayed Munsi Department of Paediatric Cardiology, Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh
Maher Akther Department of Paediatrics, Comilla Medical College and Hospital, Comilla, Bangladesh
M. Khalid Ebna Shahid Khan Department of Paediatric Cardiology, Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh
Chandan Saha Department of Paediatric Cardiology, Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2349-3291.ijcp20233954

Keywords:

VSD, ASD, PAD

Abstract

Background: Congenital heart disease (CHD) is defined by structural and functional malformations of the heart. If CHD not managed through appropriate interventions, it affects quality of life of the individual and potential premature death. Objectives were assessing the frequency and pattern of interventional procedure done in Cath lab of paediatric cardiology department, Bangladesh Shishu Hospital and Institute and their immediate outcome.

Methods: It was a cross sectional retrospective study. Total 56 patients of ventricular septal defect (VSD), atrial septal defect (ASD), patent ductus arteriosus (PDA), pulmonary stenosis (PS), aortic stenosis (AS), coarctation of aorta, pulmonary atresia, TGA from January 2019 to December 2019 who underwent trans-catheter interventional procedure by author at Cath lab of paediatric cardiology department, Bangladesh Shishu Hospital and Institute were enrolled in this study.

Results: Among 56 patients, PDA device closure done in 19, balloon pulmonary valvuloplasty (BPV) in 13 patients, device closure of ASD in 3 patients, device closure of VSD in 2 patients and balloon aortic valvuloplasty (BAV) in 1 patient. Two patients died; one is pulmonary atresia with PDA dependent pulmonary circulation following ductal stenting another is d-TGA intact IVS with PFO following BAS. One PDA device embolized and retrieved surgically from main and right pulmonary artery. Mean fluoroscopy time=17.29 and mean total procedure time=38.52 min.

Conclusions: Trans-catheter interventional procedure for PS, coarctation of aorta, PDA, ASD, VSD, AS, d-TGA, Pulmonary atresia is a safe and some procedure such as BAS for d- TGA, BPV for critical PS, Ductal stenting for pulmonary atresia, Balloon angioplasty for severe coarctation of aorta with LV dysfunction is lifesaving with a low adverse event rate.

Metrics

Metrics Loading ...

References

Yun SW. Congenital heart disease in the newborn requiring early intervention. Korean J Pediatr. 2011;54(5):183-91.

Carvalho JS. Antenatal diagnosis of critical congenital heart disease. Optimal place of delivery is where appropriate care can be delivered. Arch Dis Child. 2016;101(6):505-7.

Dolk H, Loane M, Garne E, for the European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123(8):841‑9.

Saxena A. Congenital heart disease in India: A status report. Indian J Paediatr. 2005;72(7):595‑8.

Bhat NK, Dhar M, Kumar R, Patel A, Rawat A, Kalra BP. Prevalence and pattern of congenital heart disease in Uttakhand, India. Indian J Pediatr. 2013;80(4):281‑5.

Razzaque Sk, Nahar S, Akhter S, Jahan N, Begum J. National Institute of Cardiovascular Diseases, congenital rubella, congenital heart disease and its prevention in the developing country like Bangladesh. Bangladesh Heart J. 2007;11(11):22-34.

Van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50-60.

Thiene G, Frescura C. Anatomical and pathophysiological classification of congenital heart disease. Cardiovasc Pathol. 2010;19(5):259-74.

Micheletti A. Congenital heart disease classification, epidemiology, diagnosis, treatment, and outcome. In: Flocco SF, Lillo A, Dellafiore F, Goossens E, editors. Congenital heart disease: the nursing care handbook. Cham: Springer International Publishing. 2019;1-67.

Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78(2):361-8.

Mukherjee D, Lindsay M, Zhang Y, Thomas L, Hayley O, David CC et al. Analysis of 8681 neonates with transposition of the great arteries: outcomes with and without Rashkind balloon atrial septostomy. Cardiol Young. 2010;17(4):1-8.

Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By Alfred Blalock and Helen B. Taussig. JAMA. 1984;251(16):2123-38.

Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the current era. J Thorac Cardiovasc Surg. 1997;114(1):25-30.

Gibbs JL, Rothman MT, Rees MR, Parsons JM, Blackburn ME, Ruiz CE. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J. 1992;67(3):240-45.

Lammers A, Hager A, Eicken A, Rüdiger L, Michael H, John H. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg. 2005;129(6):1353-7.

Wyss Y, Quandt D, Weber R, Brian S, Benedikt W, Walter K et al. Interventional closure of Secundum type atrial Septal defects in infants less than 10 kilograms: indications and procedural outcome. J Interv Cardiol. 2016;29(6):646-53.

Cribier A, Savin T, Saoudi N, Rocha P, Berland J. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet Lond Engl. 1986;1(8472):63-7.

Alkhouli M, Zack CJ, Sarraf M, Bashir R, Nishimura RA. Morbidity and Mortality Associated with Balloon Aortic Valvuloplasty: A National Perspective. Circ Cardiovasc Interv. 2017;10:e004481.

Prieto LR, Latson LA. Moss and Adams’ Heart Disease in Infants, Children and Adolescents Including the Fetus and Young Adult 9th ed. 2021;39;983-1007.

Kan JS, White RJ Jr, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treatment of congenital pulmonary stenosis. N Engl J Med. 1982;307(9):540-2.

Awni Al-Madani. Mid-term results of balloon pulmonary valvuloplasty in children at Queen Alia Heart institute. JRMS. 2010;17(2):47-52.

Fatema NN. Pattern of Congenital Heart Diseases and Treatment Options in a Bangladeshi Centre: Analysis of 6914 cases from Non-invasive Cardiac Laboratory. Cardiovasc J. 2017;9(2):97-105.

Tynan M, Finley JP, Fontes V, Hess J, Kan J. Balloon angioplasty for the treatment of native coarctation: results of Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol. 1990;65(11):790-92.

Porstmann W, Wierny L, Warnke H, Gerstberger G, Romaniuk PA. Catheter Closure of Patent Ductus Arteriosus: 62 Cases Treated without Thoracotomy. Radiol Clin N Am. 1971;9:203-18.

Sivakumar K, Francis E, Krishnan P, Hijazi ZM, Lloyd TR, Beekman RH 3rd et al. Safety and feasibility of transcatheter closure of large patent ductus arteriosus measuring ≥4 mm in patients weighing ≤6 kg. J Interv Cardiol. 2008;21(2):196-203.

Alireza A, Mohammadreza S. Percutaneous balloon valvuloplasty in patients with pulmonary valve stenosis: A single centre experiment. J Pak Med Asso. 2012;62(3-1):58-61.

Parra-Bravo JR, Reséndiz-Balderas M, Francisco-Candelario R, García H, Chávez-Fernández MA, Beirana-Palencia LG et al. Balloon angioplasty for native aortic coarctation in children younger than 12 months: immediate and medium term results. Arch Cardiol Mex. 2007;77(11):217-25.